United States Pharmaceutical Intermediates Markets

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

Table of Contents

United States Pharmaceutical Intermediates Markets, Executive SummaryScope of the Report and IntroductionScopeIntroduction to the U.S. Pharmaceutical Intermediates MarketSummary of Major FindingsMarket Growth, Opportunities, and Total ForecastAnalysis by Major SegmentCompetitive AnalysisMarket and Technological Trends ConclusionsUnited States Pharmaceutical Intermediates Markets, Industry Challenges, Market Drivers and Restraints, and Research MethodologyIdentification of Challenges Facing the U.S. Pharmaceutical Intermediates MarketIdentification of Challenges Facing the U.S. Pharmaceutical Intermediates MarketGrowing Pressure on Research and Development as Time to Market Gets Shorter Trend Towards Vendor Consolidation Demands Multiple Capabilities from Intermediate ManufacturersSevere Price Undercutting by Asian Companies Threaten U.S. Based Intermediate ManufacturersConsolidation of Customers Creates Larger Customers with Increased Purchasing CloutMarket Consolidation Threatens the Existence of Small and Medium Players Increased Influence of Healthcare Companies Forcing Downward Price PressuresMore Stringent and Changing Regulatory Requirements Place Additional Burden on Intermediate ManufacturersIntermediate Companies Must Cope with Periodic Slump Due to Drug Discontinuance and Patent ExpiryStrategic Partnerships Challenging Smaller PlayersHeightened Competition Due to Diversion from Agrochemical Intermediates CapacityTime Frame Analysis of Industry ChallengesTime Frame Analysis of Industry ChallengesMarket Drivers and RestraintsMarket Drivers and RestraintsMarket Drivers Market RestraintsMarket Engineering Forecasting MethodologyOverviewStrategic Significance of the Market Engineering ForecastJudging Credibility and Accuracy of Market Engineering ForecastsForecast AssumptionsGlossary of TermsList of DefinitionsList of AcronymsMarket Engineering Measurement Analysis of the U.S. Pharmaceutical Intermediates IndustryIntroductionIntroductionMarket Overview and DefinitionsMarket Overview and DefinitionsPresentation of Strategic Significance of Measurements Presentation of Strategic Significance of Measurements Market AgeMarket Size in RevenuesPotential RevenuesVolume ConsumptionBase Year Market Growth RateForecast Period Market Growth RateAverage PricePrice RangePrice SensitivityNumber of ProductsCompetitorsDegree of CompetitivenessDegree of Technical ChangeMarket ShareMarket ConcentrationMarket and Technology TrendsStrategic Partnerships with Limited Intermediate SuppliersEnvironmentally Acceptable Manufacturing MethodsIncreasing Manufacturing Capacity in the United StatesTrend Toward Chiral CompoundsCombinatorial ChemistryGenomicsDemand Analysis of the U.S. Pharmaceutical IndustryIntroductionIntroductionMarket ForecastsMarket ForecastsCardiovascular Pharmaceuticals MarketPsychotherapeutics MarketAnalgesic Pharmaceuticals MarketAnti-infectives MarketGastrointestinal Pharmaceuticals MarketRespiratory Therapies MarketCancer Therapeutics MarketObstetrics and Gynecology Pharmaceuticals MarketImmunotherapeutics MarketOther Pharmaceuticals MarketMarket Engineering Research for the U.S. Aliphatic Pharmaceutical Intermediates MarketStrategic Analysis and Forecasts of the Total MarketMarket Overview and DefinitionsMarket Engineering Research Measurement SystemMarket Engineering Unit and Revenue Forecasts (1995-2005)Market Projection by Therapeutic Areas Market Projection by Therapeutic Areas Gastrointestinal Pharmaceutical MarketsCardiovascular Therapies MarketPsychotherapeutic Pharmaceuticals MarketAnti-infectives MarketOther Pharmaceuticals MarketPricing Strategy and Trend AnalysisOther Market TrendsDemand AnalysisCompetitive AnalysisCompetitive StructureCompetitive Market Share AnalysisMarket Engineering Research for the U.S. Aromatic Pharmaceutical Intermediates MarketStrategic Analysis and Forecasts of the Total MarketMarket Overview and DefinitionsMarket Engineering Research Measurement SystemMarket Engineering Unit and Revenue Forecasts (1995-2005)Market Projection by Therapeutic Areas Market Projection by Therapeutic Areas Psychotherapeutic Pharmaceutical MarketsCardiovascular Pharmaceuticals MarketGastrointestinal Pharmaceuticals MarketRespiratory Therapies MarketOther Pharmaceuticals MarketPricing Strategy and Trend AnalysisOther Market TrendsDemand AnalysisCompetitive AnalysisCompetitive StructureCompetitive Market Share AnalysisMarket Engineering Research for the U.S. Heterocyclic Pharmaceutical Intermediates MarketStrategic Analysis and Forecasts of the Total MarketMarket Overview and DefinitionsMarket Engineering Research Measurement SystemMarket Engineering Unit and Revenue Forecasts (1995-2005)Market Projection by Therapeutic Areas Market Projection by Therapeutic Areas Cardiovascular Pharmaceutical MarketsGastrointestinal Products MarketAnti-infectives MarketAnalgesics MarketOther Pharmaceuticals MarketPricing Strategy and Trend AnalysisOther Market TrendsDemand AnalysisCompetitive AnalysisCompetitive StructureCompetitive Market Share AnalysisMarket Engineering Research for the U.S. Alicyclic and Other Pharmaceutical Intermediates MarketStrategic Analysis and Forecasts of the Total MarketMarket Overview and DefinitionsMarket Engineering Research Measurement SystemMarket Engineering Unit and Revenue Forecasts (1995-2005)Market Projection by Therapeutic AreaMarket Projection by Therapeutic AreaRespiratory Therapies MarketsAnti-infectives MarketCardiovascular Therapies MarketPsychotherapeutic Pharmaceuticals MarketOther Pharmaceuticals MarketPricing Strategy and Trend AnalysisOther Market TrendsDemand AnalysisCompetitive AnalysisCompetitive StructureCompetitive Market Share AnalysisUnited States Pharmaceutical Intermediates Markets, Selected RegulationsCurrent Good Manufacturing PracticeCurrent Good Manufacturing PracticeGuidelines for API and Pharmaceutical IntermediatesOther RegulationsOther RegulationsDrug ApprovalsUnapproved DrugsStandards for International Drug ResearchUnited States Pharmaceutical Intermediates Markets, Selected Process Technologies IntroductionIntroductionTechnologiesUnited States Pharmaceutical Intermediates Markets, Market Engineering StrategyMethodology for Identification and Development of Strategic Recommendations Based on Market Engineering PhilosophyMethodology for Identification and Development of Strategic Recommendations Based on Market Engineering PhilosophyMarket Engineering Strategic RecommendationsMarket Engineering Strategic RecommendationsMarketing DepartmentBusiness Development DepartmentResearch and Development DepartmentSales DepartmentCorporate Management




Related Research

Release Date : 20-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 18-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.